GlassScriptPhysician profile
Michael J Braun
NPI 1669428082
$849.50
in general payments reported to CMS, 2019-2025
12 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $37.82 · 2021: $182 · 2022: $182 · 2023: $12.98 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $182.44 | 2021 | |
| Baxter Healthcare | $182.44 | 2022 | |
| Heartflow, INC. | $145.96 | 2025 | |
| Neuronetics, INC. | $89.59 | 2019 | |
| Pfizer INC. | $69.94 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $53.60 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $34.53 | 2019 | |
| Amgen INC. | $27.64 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.88 | 2019 | |
| Novo Nordisk INC | $15.46 | 2025 | Wegovy |
| Biocompatibles, INC. | $13.04 | 2019 | |
| Urgo Medical North America, LLC | $12.98 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.